Device / Technology News

RSS

Austrian Institute of Technology adopts Arrayit's Microarray Platform for detecting dangerous pathogens

Arrayit Corporation, a proprietary life sciences and technology leader, disclosed that its Microarray Platform has been adopted by Austrian Institute of Technology.

28 Sep 2009

New Fragment Screening Platform from Selcia

Selcia Ltd, a worldwide industry leading C-14 custom radiolabelling provider and drug discovery company this week launched their new Fragment Screening Platform and unveiled their new brand as part of ambitious international expansion plans.

28 Sep 2009

New scalable solutions for targeted re-sequencing studies from febit holding and Life Technologies

febit holding GmbH and Life Technologies Corporation today announced that they have entered into a strategic co-marketing agreement to provide a new, scalable solution for researchers conducting targeted re-sequencing studies. In addition, febit will expand its Genomic Services Facility at Heidelberg by adding several Applied Biosystems SOLiD™ high-throughput sequencing systems and real-time PCR systems.

28 Sep 2009

MedShape Solutions to launch the FDA-cleared Morphix Suture Anchor device

MedShape Solutions, Inc. announced today the first FDA cleared shape memory PEEK (polyaryletheretherketone) device for orthopedics using proprietary shape memory PEEK Altera(TM) material. The Morphix(TM) Suture Anchor was recently granted FDA clearance and will be released to select U.S. markets in the coming months. Over $2.5B of PEEK-based implants are sold every year in the field of orthopedics.

28 Sep 2009

BIOLASE to market its Waterlase MD products in China

BIOLASE Technology, Inc. today announced that it finalized three regional distribution agreements in the People's Republic of China. This announcement follows the Company's August 12, 2009, announcement that it had received regulatory approval to market its Waterlase MD™ products in China.

28 Sep 2009

MedPro and Advanced MedTech to develop new passive needlestick injury prevention technologies

MedPro Safety Products, Inc. (OTCBB: MPSP), a pioneer in the development and marketing of passive needlestick injury prevention technology, entered into an exclusive agreement with Advanced MedTech (AMT). AMT is wholly owned by Hooman Asbgahi, the inventor of MedPro’s phlebotomy products, marketed by Greiner Bio-One GmbH under its VACUETTE® brand as the VACUETTE® PREMIUM Safety Needle System and VACUETTE® PREMIUM Blood Collection Set.

28 Sep 2009

Thommen Medical launches two implant conditioning systems

Thommen Medical, a leading Swiss company in the area of the oral implantology, will officially launch the latest products in the evolution of implant surface technology, APLIQUIQ and INICELL, at the 2009 AAOMS Meeting in Toronto, Canada.

28 Sep 2009

Increment in 2010 PET reimbursement may increase the demand for Cardiac PET imaging

Positron Corporation, a molecular imaging solutions company focused on Nuclear Cardiology, predicts a significant rise in demand for Cardiac PET in 2010 with a proposed cut in SPECT reimbursement of 46% and an increase in PET reimbursement of 22%, issued by the Centers for Medicare & Medicaid Services (CMS).

28 Sep 2009

Preliminary results from procedural review of Menaflex released by the FDA

The U.S. Food and Drug Administration (FDA) yesterday released preliminary results of a review of its internal procedures surrounding the review of ReGen Biologics’Menaflex collagen meniscus implant for use in the U.S.

28 Sep 2009

UTAS chooses ADI Blackfin processors to ensure high quality patient care

Analog Devices, Inc. (NYSE: ADI) today announced that UTAS, a provider of medical devices for patient monitoring and diagnostics, has selected ADI Blackfin® processors to ensure high-performance digital signal processing operations and robust functionality across its full line of products.

28 Sep 2009

First heart surgery using MECC system completed

MAQUET Cardiovascular announced today that Johannes Bonatti, M.D., Professor of Surgery and Director of Coronary Surgery and Advanced Coronary Interventions at the University of Maryland Heart Center in Baltimore, has completed the world's first use of the MAQUET Minimized ExtraCorporeal Circulation (MECC) system during a successful robotic and fully endoscopic heart surgery. The new cardiopulmonary bypass technology is the first major advancement in perfusion technology in the last decade. It is designed to minimize the effects of traditional heart surgery and aid in minimally-invasive heart surgery without the need to stop the patient's heart from beating.

28 Sep 2009

S&P Consultants and Vedant collaborate to increase patient safety in Cerner Millennium implementations

A new business partnership of S&P Consultants, Inc. and Vedant Incorporated will now offer the highest levels of quality- and patient-safety assurance to both standard and customized applications built on the Cerner Millennium® platform. Both companies have particular expertise in the Cerner Millennium® environment, with S&P providing a broad range of consulting services and Vedant offering TestStream®, a comprehensive suite of software testing and validation solutions for systems of all levels of complexity and scale.

26 Sep 2009

Network in Canada to develop biomaterials for treatment of eye diseases

Researchers in Canada have established a new university/industry network to pursue the development of biomaterials, medical devices and drug delivery systems to treat the increasing incidence of eye disease.

26 Sep 2009

ProSperus, Genesis Physicians Group launch GenPro Practice Management Solutions

ProSperus, a Mequon, Wis.,-based, full-service practice management company, and Genesis Physicians Group, a Dallas-based independent physicians association (IPA), today announced the launch of GenPro Practice Management Solutions.

26 Sep 2009

Sonomax signs five year licensing agreement with Dutch company

Sonomax Hearing Healthcare Inc. (TSX Venture: SHH) announces that it has signed a five year licensing agreement with a newly formed Dutch company which has adopted the name Sonomax Europe BV (hereafter SEBV) with Sonomax's approval. Sonomax is not a stakeholder in SEBV.

26 Sep 2009

NSF funds UAB to purchase highly-specialized imaging system

The National Science Foundation has awarded $431,200 to the University of Alabama at Birmingham (UAB) Department of Physics to facilitate the purchase of a new highly-specialized imaging system - the first of its kind in Alabama - that will be a centerpiece of a new interdisciplinary research laboratory on campus.

26 Sep 2009

Initial clinical results for Mpathy Medical's Omnisure sling released

Mpathy Medical, a rapidly growing medical device company which has developed and brought to market a range of less invasive surgical solutions used to restore pelvic health to women, released the initial clinical results for its newest product, Omnisure™, a novel full length sling for treatment of female stress urinary incontinence (SUI) at the American Urogynecologic Society’s (AUGS) Annual Meeting.

26 Sep 2009

PureSafety's OHM solutions at Salem Hospital

Salem Hospital, a 464-acute care non-profit hospital that operates the busiest emergency department in Oregon, has partnered with PureSafety to utilize the company’s Occupational Health Manager® (OHM) solutions to streamline the hospital’s occupational health and medical management processes.

26 Sep 2009

HORIZONS-AMI clinical trial demonstrates efficacy of drug-eluting stent

Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare-metal stent; and that the administration of the anticoagulant medication bivalirudin enhanced safety and efficacy compared to the use of heparin + GPIIb/IIIa inhibitors.

25 Sep 2009

RXi Pharmaceuticals acquires self-delivering rxRNA technology platform from Advirna

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it has recently acquired direct ownership of technology for which it had previously exercised its option to exclusively license from Advirna LLC.

25 Sep 2009